Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
Current status of biomarker research in neurology.
Anthraquinones As Pharmacological Tools and Drugs.
Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects.
Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals sympathoexcitatory centers during hypertension.
An unusual case of acute transverse myelitis caused by HSV-1 infection.
The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis.
Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.
Intra-rater reliability of the Modified Tardieu Scale in patients with multiple sclerosis.
Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire.
Variable Density Magnetization Transfer (vdMT) imaging for 7 T MR Imaging.
A combined exercise model for improving muscle strength, balance, walking distance, and motor agility in multiple sclerosis patients: A randomized clinical trial.
Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Prevalence of anti-SOX1 reactivity in various neurological disorders.
Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection.
[Multiple Sclerosis and Commensal Gut Flora].
Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia.
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.
Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population.
Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination.
Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
779
780
781
782
783
784
785
786
787
…
next ›
last »